Vivo Capital IX, LLC
- SEC CIK
- 0001750698
No open-market purchases or sales filed in the past year.
Current role at each company
- IOBT IO Biotech, Inc.10% Owneras of Aug 10, 2023
- SRRA Sierra Oncology, Inc.Director, 10% Owneras of Jul 1, 2022
- TARS Tarsus Pharmaceuticals, Inc.10% Owneras of May 5, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Vivo Capital IX, LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IOBT IO Biotech, Inc.
10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2023 (view filing)9:03 AM ET | Aug 9 | 1 day | Vivo Opportunity, LLC and 3 others10% Owner | PPurchase | +3.16M | $1.90 | +$6.00M | New position3.16M after | |
| Aug 10, 2023 (view filing)9:03 AM ET | Aug 9 | 1 day | Vivo Opportunity, LLC and 3 others10% Owner | PPurchase | +3.16M | $0.125 | +$394.7K | –3.16M after | Derivative |
| Nov 12, 2021 (view filing)4:16 PM ET | Nov 9 | 3 days | Vivo Capital Fund IX, L.P. and 1 other10% Owner | PPurchase | +650.0K | $14.00 | +$9.10M | +27.5%3.02M after | Duplicate filing |
TARS Tarsus Pharmaceuticals, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 5, 2022 (view filing)6:55 PM ET | May 5 | Same day | Vivo Capital Fund IX, L.P. and 1 other10% Owner | SSale | −5.37K | $12.25 | −$65.8K | −0.2%2.47M after | |
| May 4, 2022 (view filing)8:01 PM ET | May 2-4 | 2 days | Vivo Capital Fund IX, L.P. and 1 other10% Owner | SSale | −513.0K | $13.39 | −$6.87M | −17.2%2.47M after | 3 lots |
SRRA Sierra Oncology, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2022 (view filing)9:30 PM ET | Jan 31 | Same day | Vivo Ventures Fund VII, L.P. and 6 others10% Owner | PPurchase | +800.0K | $27.00 | +$21.6M | +41.3%2.74M after | Duplicate filing |